urticaria treatment Psoriasis Vulgaris treated by Dr Rajesh Shah at Life Force – Video


urticaria treatment Psoriasis Vulgaris treated by Dr Rajesh Shah at Life Force
http://x.vu/urticaria Why Can #39;t Doctors Cure Your Hives? I think I know... The inside story on Dr. Gary M. Levin #39;s remarkable Hives and Angioedema Cure "Read on to discover what really...

By: urticaria

Go here to see the original:

urticaria treatment Psoriasis Vulgaris treated by Dr Rajesh Shah at Life Force - Video

Psoriasis: Symptoms, Pictures, Causes, and Treatments

Psoriasis is a chronic skin disease characterized by red patches on the skin, often accompanied by silvery-white scales of dead skin cells. It is not contagious.

Psoriasis is believed to be an autoimmune disease, meaning the body's defense system attacks healthy cells in the body. This creates skin cells that mature and die in less than a week, which is extremely rapid considering normal skill cells mature and replace dead ones usually in a month's time.

The buildup of dead cells on the skin's surface is called plaque. While these can occur anywhere on the body, they are more common in the following areas:

The National Psoriasis Foundation estimates that as many as 7.5 million Americans and 125 million people worldwide (about 2.2 percent of the population) have psoriasis, making it the most prevalent autoimmune disease in the world.

While psoriasis affects the skin, it goes beyond a cosmetic problem. The exterior symptoms of psoriasis can affect a person's self-esteem and personal image, which can create problems in their everyday lives such as anxiety and alienation.

There are several different types of psoriasis, distinguished by 1) the affected area of the body and 2) the type of patches. They include:

This type involves plaques on the scalp that typically can be confused as dandruff. About half of all people with any type of psoriasis also have scalp psoriasis.

Found anywhere on the body, plaque psoriasis is the most common form of psoriasis. Small red bumps spread and dead skin cells easily flake from those areas.

This type of psoriasis involves smooth inflamed lesions in areas where the skin folds or flexes, such as the armpits, groin, or under the breast.

This kind causes severe disruption to the body's chemical balance, affecting the majority of the body, and causes symptoms such as severe scaling, pain, and itching to the point where the skin looks as though it has been burned. It can also cause severe illness.

Read this article:

Psoriasis: Symptoms, Pictures, Causes, and Treatments

Systemic Psoriasis Therapeutics in Major Developed Markets to 2020 – Continued Uptake of Biologics and Novel Pipeline …

Albany, NY (PRWEB) February 06, 2014

Systemic Psoriasis Therapeutics in Major Developed Markets to 2020 - Continued Uptake of Biologics and Novel Pipeline Drugs to Drive Growth Description

Research has released its pharma report Systemic Psoriasis Therapeutics in Major Developed Markets to 2020 - Continued Uptake of Biologics and Novel Pipeline Drugs to Drive Growth. The systemic psoriasis market is forecast to grow substantially over the forecast period from $5.0 billion in 2013 to $10.4 billion in 2020, across the eight major markets. This growth will be driven by a rising treatment population and the continued uptake of biologics. Biologics will continue to drive market growth despite leading brands Enbrel (etanercept), Humira (adalimumab) and Remicade (infliximab) losing patent protection in most of the major markets over the forecast period. Although the market will suffer revenue losses as a result of sales erosion from biosimilar competitors, this will be offset by the emergence of novel therapies. Most notably, these include monoclonal antibodies secukinumab, ixekizumab and brodalumab, which are currently being developed by Alcon (Novartis subsidiary), Eli Lilly and Amgen, respectively.

To Buy The Copy of This Report Visit: http://www.marketresearchreports.biz/analysis/186872

Scope

An introduction to psoriasis, which includes symptoms, epidemiology, etiology, pathophysiology, diagnosis and treatment Analysis of the major systemic therapies in the current psoriasis marketed landscape Analysis of the pipeline for psoriasis, which includes a breakdown of pipeline molecules by phase of development, molecule type, molecular target and novelty. Psoriasis clinical trials are analyzed by size, duration and failure rates, and a comparative analysis of the most promising systemic pipeline molecules is also provided. Forecast projections for the systemic psoriasis market to 2020. Analysis is provided for the global market and each of the eight major markets. The forecast incorporates projected, low and high variance scenarios based on treatment usage patterns and annual therapy costs in each of the major markets. Analysis of strategic consolidations, including co-development and licensing deals, within the psoriasis indication

Reasons to Buy

Understand the current systemic psoriasis marketed products landscape and recognize the dominant therapeutic agents and pharmaceutical players involved Identify trends and developments within the psoriasis pipeline and consider how the future competitive environment will be impacted Consider market opportunities and potential risks by examining the psoriasis clinical trial landscape in relation to industry averages Observe projections for treatment usage patterns, annual therapy costs and market growth in the eight major markets and understand reasons for variance in projected patterns of growth in the eight major markets

To Get Download Full Report with TOC: http://www.marketresearchreports.biz/sample/sample/186872

Table of Content

See the rest here:

Systemic Psoriasis Therapeutics in Major Developed Markets to 2020 - Continued Uptake of Biologics and Novel Pipeline ...

Tests That Diagnose Psoriatic Arthritis

By Bethany Afshar WebMD Feature

If you are one of the 7 million people in the United States who have the skin condition psoriasis, you should know the signs and symptoms of psoriatic arthritis. As many as 40 percent of people with psoriasis also have psoriatic arthritis.

The causes of psoriasis and psoriatic arthritis are not completely understood. Genetics, the environment, and your immune system are all thought to play roles. Some scientist believe that your immune system attacks your skin when you have psoriasis. When you have psoriatic arthritis, it attacks the joints, causing inflammation.

It can be hard to find out you have psoriatic arthritis. There are no significant tests that can be done to support diagnosis. Doctors must exclude other types of arthritis, and patients must have a history of psoriasis or have active psoriasis to get the diagnosis, says Erin Boh, MD, chairman of dermatology at Tulane University Health Sciences Center in New Orleans.

Your joint symptoms may be mild, so your doctor may suspect other typical causes of pain, says Eric Matteson, MD, rheumatology chair at Mayo Clinic in Rochester, MN.

The first symptoms may not seem related to your skin condition, Matteson says. But that stiffness in your back may be caused by spine inflammation. Its important to get a correct diagnosis so that you can be treated before your joints have permanent damage.

The condition can develop very slowly. In most cases, a person will develop or have psoriasis before he has signs of psoriatic arthritis.

In the less common cases where joint problems show up before the skin symptoms, it can be even more difficult to diagnose. When it does affect the joints of the arms and legs, it can cause swelling that looks like rheumatoid arthritis and be confused with this disease, Matteson says.

Your doctor will ask you questions about your medical and family histories, as well as examine you for swollen and tender joints. You may have an X-ray to see if you have joint damage, and blood tests can help rule out other diseases.

Skin specialists, known as dermatologists, are often the first to suspect psoriatic arthritis in people theyre treating for psoriasis.

The rest is here:

Tests That Diagnose Psoriatic Arthritis